BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//MediWales - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://medi.twsdev1.com
X-WR-CALDESC:Events for MediWales
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20120325T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20121028T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20130331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20131027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20140330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20141026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20150329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20151025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20160327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20161030T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20150208
DTEND;VALUE=DATE:20150213
DTSTAMP:20260620T182921
CREATED:20150109T135744Z
LAST-MODIFIED:20150109T135744Z
UID:10093-1423353600-1423785599@medi.twsdev1.com
SUMMARY:Oncology & Drug Discovery Mission to India
DESCRIPTION:Register now to represent the very best of British innovation in a thriving market\n8 – 12 February 2015\nRegister now to join UK Trade & Investment’s Oncology market visit to India. This mission will focus on India’s two leading cities in the field of Oncology – Bangalore and Mumbai – and coincide with India’s flagship Biotechnology event\,Bangalore India Bio. \nLed by Business Ambassador\, Harriet Fear\, the mission will start in Bangalore – considered the hub for drug discovery and research in India – before moving to Mumbai on the 3rd day. \nHere\, the delegation will link with Healthcare UK’s activity during the same period\, culminating in a high profile\, collective presence to promote the Best of British in Life Sciences\, Healthcare and UK innovation. \nMission Benefits \n\nMeet with 300+ Pharma\, Biotech and Healthcare companies\, including company visits to key organisations: Tata Memorial and Cipla in Mumbai\, Biocon and NCBS in Bangalore\nBe a part of the UK presence at India’s flagship Biotechnology event\,Bangalore India Bio\nTake part in Drug Discovery and Innovation workshops\, key seminar sessions\, and exclusive networking events\, including the Best of\nBritish reception in Mumbai with Healthcare UK’s mission delegation\nYour mission presence will be extended via the mission brochure\, as well as with local media and press coverage\n\nIs it for me? \nThis mission is suited to organisations working on Oncology or in drug discovery\, particularly those with interest in: \n\nResearch and development\nPlatform technologies\nGenome sequencing\nMedical devices\nScreening and diagnostics\n\n  \nFind out more: \nW: www.events.ukti.gov.uk/india-oncology–drug-discovery-mission/\nE: IndiaOncology@uktieventspecialist.co.uk\nT: 020 7034 4848 \nFor logistical support\, such as hotel options and visa contacts\, please email the above address for further information. \n  \nIndia is the world’s third largest country affected by new cases of cancer\, after the US and China. \nThe key areas of focus in Oncology in India are breast cancer\, colorectal cancer\, lung cancer\, NHL and prostate cancer. \nThe market is expected to grow at a compounded rate of 6.5% per annum to $240 million by 2018. \n 
URL:https://medi.twsdev1.com/event/oncology-drug-discovery-mission-india/
LOCATION:TX
CATEGORIES:External,International Events
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20150127T093000
DTEND;TZID=Europe/London:20150127T101559
DTSTAMP:20260620T182921
CREATED:20150114T153939Z
LAST-MODIFIED:20150114T153939Z
UID:10095-1422351000-1422353759@medi.twsdev1.com
SUMMARY:UKTI Japan Webinar: CMIC Co.\, Ltd: Regulatory Developments in Japan's Medical Devices Market
DESCRIPTION:British Embassy Tokyo Webinar: CMIC Co.\, Ltd: Regulatory Developments in Japan’s Medical Devices Market \nPlease register via Export to Japan website. \nUK Trade and Investment Japan Life Sciences Team would like to invite you to the webinar by CMIC Co.\, Ltd who will talk about the recent regulatory developments in Japan’s medical devices market. \nThis is an opportunity to find out about the recent changes to Japan’s Pharmaceutical Affairs Law and how this will affect British companies\, especially for medical devices related companies and institutions wishing to do business in Japan. \nSpeaker \nMs. Fukuko Arai\, Certified Business Management Consultant\, Manager\, Medical Devices Consulting Group\, Medical Devices Division\, CMIC Co.\, Ltd \nBenefits of participation \nThis webinar will explain: \n\nRecent regulatory developments on medical devices in Japan.\nHow CMIC will be able to support UK medical devices companies with smooth and effective entry to the Japanese medical devices market.\n\nYou will have the opportunity to interact with the speaker by asking text questions during the Q&A session. Questions can also be sent directly to info@exporttojapan.co.uk.
URL:https://medi.twsdev1.com/event/ukti-japan-webinar-cmic-co-ltd-regulatory-developments-japans-medical-devices-market/
LOCATION:TX
CATEGORIES:External,International Events
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20131015
DTEND;VALUE=DATE:20131017
DTSTAMP:20260620T182921
CREATED:20130501T133049Z
LAST-MODIFIED:20130501T133049Z
UID:7960-1381795200-1381967999@medi.twsdev1.com
SUMMARY:ABHI 2013: Making sense of uncertainty: the impact of reforms
DESCRIPTION:ABHI is pleased to be launching their inaugural UK medical technology conference which will focus on the key areas: Regulatory\, UK Market and International. \nClick here to register \nThe medical technology industry faces huge changes to the environment in which it operates in the UK. \nReforms are everywhere. A commissioning-led NHS means imperatives and a landscape that are very different to that which has been in existence. The current regulatory system is deemed to be not enough and proposals to amend will mean significant alterations. With significant growth coming from overseas markets\, industry needs to fully understand where these opportunities exist and how best to prepare for the challenges posed by trading globally . \nThese changes are happening now. They cannot be seen in isolation – they carry real risk but also significant opportunity. They are numerous\, complex\, and impact multiple areas of businesses. Understanding and responding to that impact is becoming increasingly challenging for industry. \nOver the course of 2 days\, ABHI 2013: The MedTech Conference will provide clarity of what these changes mean. Various plenaries\, panel discussions and workshop sessions will provide delegates with a comprehensive overview of the key issues affecting future success. \nWhy you should attend: \n\nReceive the latest insights from thought leaders and decision makers\nUnderstand critical strategic trends that will impact your business\nGain practical benefit from focussed workshops\nInteract with senior NHS leaders\, Government officials\, and Parliamentarians\nNetwork with your peers and industry stakeholders
URL:https://medi.twsdev1.com/event/abhi-2013-making-sense-of-uncertainty-the-impact-of-reforms/
LOCATION:The Mermaid Theatre\, Blackfriars\, London\, EC4V 3DB\, United Kingdom
CATEGORIES:External,International Events
ORGANIZER;CN="Liz Carrington":MAILTO:liz.carrington@abhi.org.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20130923
DTEND;VALUE=DATE:20130926
DTSTAMP:20260620T182921
CREATED:20130509T133457Z
LAST-MODIFIED:20130509T133457Z
UID:8003-1379894400-1380153599@medi.twsdev1.com
SUMMARY:AdvaMed 2013: Welsh Government trade mission
DESCRIPTION:AdvaMed 2013 is the leading MedTech conference in North America\, bringing more than 1\,000 companies together in a uniquely multifaceted environment for business development\, capital formation\, innovative technology showcasing\, world-class educational opportunities and networking. An event rich in international flavour and featuring a deep\, diverse attendee list that includes influential policymakers\, business executives and media. AdvaMed 2013 seeks to advance industry discussion from key perspectives through detailed panel sessions\, executive forums and more. \nThe events agenda over the three days covers a range of topics such as courses\, panel sessions/workshops\, partnering meetings\, company presentations and networking sessions. The full agenda can be seen here. \nTo learn more about Advamed 2013 please visit the following link: Advamed2013.com \nWhen joining the trade exhibition\, Welsh companies will benefit from comprehensive support and services: \n\n50% funding towards travel\, accommodation\nCompanies seeking market reports can benefit from 75% subsidy Market Visit. Please contact me now to apply for the Welsh Government International Trade Opportunity support.\nFollow-up to the event can be assisted by the Welsh Government staff based in the US\n\nThe increasing demand from companies around the world to attend Advamed means that space is limited and we therefore ask that interested companies please register interest by contacting Karine Davies on 07789 371306 or Karine.Davies@wales.gsi.gov.uk.
URL:https://medi.twsdev1.com/event/advamed-2013-welsh-government-trade-mission/
LOCATION:Walter E. Washington Convention Center\, WA\, United States
CATEGORIES:External,International Events
ORGANIZER;CN="Karine Davies":MAILTO:Karine.Davies@wales.gsi.gov.uk
END:VEVENT
END:VCALENDAR